ASPR Makes Second Defense Production Act Award For API Production

The Administration for Strategic Preparedness and Response (ASPR) will spend another $17.5 million to boost innovative manufacturing of active pharmaceutical ingredients (API) in the United States, HHS announced Tuesday (Oct. 1), the second award funded by ASPR’s Defense Production Act program. The investments are through ASPR’s Center for Industrial Base Management and Supply Chain program under the Defense Production Act’s Title III, part of a program to help mitigate drug shortages as a national defense measure. Private companies National Resilience...